A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
CongXiao Zhang,*,1,2 XinWang Zhu,*,1 LuLu Li,1 TianKui Ma,1 Mai Shi,1 Ying Yang,1 QiuLing Fan11Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China; 2Blood Purification Center, Shenyang the 4th Hospital of People, Shenyang 11...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/83590df8cfef47f1a8c6e154af6ab4ff |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!